Volume 14, Issue 1 (Int J Mol Cell Med 2025)                   Int J Mol Cell Med 2025, 14(1): 462-471 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadi H, Shakiba E, Rostampour R, Bahremand K, Goodarzi M T, Bashiri H, et al . Down expression of Zyxin is associated with down expression of p53 in Colorectal cancer. Int J Mol Cell Med 2025; 14 (1) :462-471
URL: http://ijmcmed.org/article-1-2420-en.html
1- Department of Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran.
2- Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
3- Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
4- Department of Biochemistry, Shahrood Branch, Islamic Azad University, Shahrood, Iran.
5- Department of Internal Medicine, Infectious Disease Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
6- Department of Biostatistics, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran.
7- Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran , sohila.asadi75@yahoo.com
Abstract:   (718 Views)
Colorectal cancer (CRC), which is among the most prevalent cancers worldwide, is caused by environmental and genetic factors. It has been shown that the p53 gene is associated with CRC pathogenesis; moreover, Zyxin (ZYX) may play a role in p53 level and activity. Therefore, the present research aimed to investigate the levels of P53 and ZYX genes and proteins in CRC tumor samples. Cancerous tissues (n=31) and matched non-cancerous tissues (n=31) were randomly obtained from 31 patients with CRC. Total RNA was extracted using RNXplus, and gene expressions were assessed by Real-time PCR. Furthermore, the Western blot technique was used to investigate the expression of ZYX and P53 proteins. The obtained results revealed that the expression of ZYX and p53 genes in cancerous tissues showed no significant difference compared to matched non-cancerous tissues. On the other hand, measuring protein expression using the Western blotting technique indicated that the ZYX (P=0.0081) and p53 (P=0.0065) expression in tumor tissues significantly decreased compared to those in matched non-cancerous tissues. Correlation analysis indicated a significant correlation between ZYX and P53 proteins (r=0.746, P=0.013). Based on our findings, ZYX might have a suppressive function in CRC and is associated with P53.
Full-Text [PDF 662 kb]   (237 Downloads)    
Type of Study: Original Article | Subject: Cancer
Received: 2024/08/23 | Accepted: 2024/11/13 | Published: 2025/01/12

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | International Journal of Molecular and Cellular Medicine IJMCM

Designed & Developed by : Yektaweb